Menu Search
Equities

Cryoport Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CKX:STU

Cryoport Inc

Actions
  • Price (EUR)7.40
  • Today's Change0.10 / 1.37%
  • Shares traded0.00
  • 1 Year change+8.82%
  • Beta1.6907
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

  • Revenue in USD (TTM)190.26m
  • Net income in USD-52.13m
  • Incorporated1990
  • Employees1.09k
  • Location
    Cryoport Inc112 Westwood Place, Suite 350BRENTWOOD 37027United StatesUSA
  • Phone+1 (949) 232-1900
  • Fax+1 (949) 470-2306
  • Websitehttps://www.cryoport.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.